FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-9.55%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$307M
AUM Growth
+$307M
(-16%)
Cap. Flow
-$17.3M
Cap. Flow
% of AUM
-5.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Cartesian Therapeutics
RNAC
|
$14.1M |
| 2 |
Carisma Therapeutics
CARM
|
$1.97M |
| 3 |
TTOO
T2 Biosystems, Inc
TTOO
|
$1.19M |
Sector Composition
| 1 | Healthcare | 96.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Seres Therapeutics
MCRB
$166M
| $126M | 40.85% |
12,682,876
| – | – |
|
|
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $58.4M | 19.02% |
4,806,656
| – | – |
|
3
Editas Medicine
EDIT
$231M
| $56.1M | 18.25% |
3,455,316
| – | – |
|
4
Agios Pharmaceuticals
AGIO
$2.19B
| $40.3M | 13.11% |
965,369
| – | – |
|
|
5
Cartesian Therapeutics
RNAC
$261M
| $14.2M | 4.61% |
826,862
-825,000
| -50% | -$14.1M |
|
|
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
| $10.3M | 3.34% |
1,950,583
-225,584
| -10% | -$1.19M |
|
|
7
Carisma Therapeutics
CARM
$8.98M
| $2.53M | 0.82% |
1,324,018
-1,030,692
| -44% | -$1.97M |
|